⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28646765 | 0.72 | — | — | |
| SCHEMBL28638745 | 0.71 | — | — | |
| SCHEMBL29224558 | 0.71 | — | — | |
| SCHEMBL30380526 | 0.68 | — | — | |
| SCHEMBL22193800 | 0.67 | — | — | |
| SCHEMBL29259049 | 0.60 | — | — | |
| SCHEMBL9223567 | 0.60 | — | — | |
| SCHEMBL3486076 | 0.60 | — | — | |
| SCHEMBL29203710 | 0.58 | — | — | |
| SCHEMBL2374044 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | claimed |
| US-11624090-B2 | Manipulating the translation of DNA strands across and through nanopore sequencing systems using Raman signatures to identify DNA bases and methods | ARMONICA TECHNOLOGIES, INC. (US) | 2023-04-11 | — | — | US | claimed |
| EP-3911441-A1 | MANIPULATING THE TRANSLATION OF DNA STRANDS ACROSS AND THROUGH NANOPORE SEQUENCING SYSTEMS USING RAMAN SIGNATURES TO IDENTIFY DNA BASES AND METHODS | Armonica Technologies, Inc. (US) | 2021-11-24 | — | — | EP | claimed |
| WO-2020150140-A1 | MANIPULATING THE TRANSLATION OF DNA STRANDS ACROSS AND THROUGH NANOPORE SEQUENCING SYSTEMS USING RAMAN SIGNATURES TO IDENTIFY DNA BASES AND METHODS | ARMONICA TECHNOLOGIES, INC. (US) | 2020-07-23 | — | — | WO | claimed |
| US-20200224263-A1 | MANIPULATING THE TRANSLATION OF DNA STRANDS ACROSS AND THROUGH NANOPORE SEQUENCING SYSTEMS USING RAMAN SIGNATURES TO IDENTIFY DNA BASES AND METHODS | ARMONICA TECHNOLOGIES, INC. | 2020-07-16 | — | — | US | claimed |
| US-20260028668-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-01-29 | — | — | US | disclosed |
| EP-4565717-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-06-11 | — | — | EP | disclosed |
| CN-118829423-A | Compositions for delivery of payload molecules to airway epithelium | 摩登纳特斯有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024181391-A1 | IL-11 ANTISENSE OLIGONUCLEOTIDE | 日産化学株式会社 | 2024-09-06 | — | — | WO | disclosed |
| CN-118019526-A | Methods for preparing lipid nanoparticle compositions for delivery of payload molecules to airway epithelium | 摩登纳特斯有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-118019527-A | Method for preparing lipid nanoparticle compositions | 摩登纳特斯有限公司 | 2024-05-10 | — | — | CN | disclosed |
| WO-2024028866-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-02-08 | — | — | WO | disclosed |
| US-9592277-B2 | Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases | AVIRID, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-20090047272-A1 | Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases | NANONASE, INC. | 2009-02-19 | — | — | US | disclosed |
| EP-1383497-B1 | CARBONIC ANHYDRASE ACTIVATORS FOR ENHANCING LEARNING AND MEMORY | BRNI NEUROSCIENCES INST (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1734991-A2 | COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES | Avirid, Inc. (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005115444-A2 | COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES | AVIRID, INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| EP-0203968-A4 | METHOD FOR IMMUNOANALYSIS OF CHOLESTEROL EPOXIDES. | SCHAFFNER CARL P | 1989-06-14 | — | — | EP | disclosed |
| EP-0203968-A1 | METHOD FOR IMMUNOANALYSIS OF CHOLESTEROL EPOXIDES. | SCHAFFNER CARL P | 1986-12-10 | — | — | EP | disclosed |
| WO-1986003299-A1 | METHOD FOR IMMUNOANALYSIS OF CHOLESTEROL EPOXIDES | SCHAFFNER CARL P | 1986-06-05 | — | — | WO | disclosed |